The chief of the Task Group on Vaccine Evaluation and Selection (TG-VES) is not surprised by the decision of the Food and Drug Administration (FDA) to issue an emergency use authorization (EUA) to the coronavirus disease (COVID-19) vaccine developed by United States-drug company Moderna.
“This is expected since Moderna received EUA in other countries with stringent regulatory authorities (SRAs),” Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara said in a VIber message to the Manila Bulletin on Wednesday, May 5.
DOST Secretary Fortunato “Boy” T. de la Peña also cheered at the FDA’s EUA grant to the Moderna’s coronavirus jab.
“Again any additional authorized vaccine improves our access at an earlier period,” he said.
He maintained that more vaccines with EUA approved by FDA means more vaccines can enter the country adding to the adequacy of supply.
FDA Director-General Rolando Enrique Domingo announced Wednesday, May 5, that the Moderna vaccine has been granted an EUA.
Moderna vaccine is the seventh COVID-19 jab listed for emergency use by FDA.